Draft Genome Sequence of a Leptospira kirschneri Serovar Mozdok Type 2 Strain Isolated from a Horse in Portugal

João Inácio; Antonio Muñoz-Mérida; Ahmed A Ahmed; Teresa Rocha; João Rodrigo Mesquita; Gertrude Thompson; Marga G A Goris; Rudy A Hartskeerl; Ana Sofia Ferreira

doi:10.1128/MRA.00217-21

Draft Genome Sequence of a Leptospira kirschneri Serovar Mozdok Type 2 Strain Isolated from a Horse in Portugal

Microbiol Resour Announc. 2021 Jul 15;10(28):e0021721. doi: 10.1128/MRA.00217-21. Epub 2021 Jul 15.

Authors

João Inácio^#^{1

2}, Antonio Muñoz-Mérida^#³, Ahmed A Ahmed⁴, Teresa Rocha⁵, João Rodrigo Mesquita^{6

7}, Gertrude Thompson^{3

7}, Marga G A Goris⁴, Rudy A Hartskeerl⁴, Ana Sofia Ferreira^{6

8}

Affiliations

¹ Unidade de Microbiologia Médica, Global Health and Tropical Medicine, Instituto de Higiene e Medicina Tropical, Universidade Nova de Lisboa, Lisbon, Portugal.
² School of Pharmacy and Biomolecular Sciences, University of Brighton, Brighton, United Kingdom.
³ Research Center in Biodiversity and Genetic Resources, University of Porto, Vila do Conde, Portugal.
⁴ OIE and National Collaborating Centre for Reference and Research on Leptospirosis, Academic Medical Center, Department of Medical Microbiology, University of Amsterdam, Amsterdam, the Netherlands.
⁵ Instituto Nacional de Investigação Agrária e Veterinária, I.P., Unidade Estratégica de Produção e Saúde Animal, Oeiras, Portugal.
⁶ Epidemiology Research Unit, Instituto de Saúde Pública da Universidade do Porto, Porto, Portugal.
⁷ Institute of Biomedical Sciences Abel Salazar, University of Porto, Porto, Portugal.
⁸ Laboratory of Microbiology, Department of Biological Sciences, Faculty of Pharmacy, University of Porto, Porto, Portugal.

^# Contributed equally.

Abstract

Leptospira kirschneri is an agent causing leptospirosis in animals and humans. We report the draft genome sequence of Leptospira kirschneri serovar Mozdok type 2 strain Horse 112, comprising 485 contigs and having a genome size of 4,301,784 bp. This genome will facilitate studying important mechanisms for clinical outcomes.